Read our news

HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisition includes Modern Meadow’s platform of recombinant proteins, with the most advanced product being human recombinant collagen type III (rhCOL3).

As every year, the In-Cosmetics Global Congress returns to Paris, with top industry leaders and experts gathering under one roof.
This event promises opportunities and insights into the future of Cosmetics.

France BioLead structures, pilots, supports and promotes the French biomanufacturing sector.

AMWC, the Aesthetic & Anti-Aging Medicine World Congress in Monaco.

PCHi is an annual gathering of professionals from the cosmetics and aesthetics industry, featuring formulators, manufacturers and R&D experts from all over the world. 

Discussion between Ted Lain, American dermathologist and François Fournier about the key role played by HTL Biotechnology in aesthetic medicine.

The 35th edition of CIBE in Guangzhou attracted over 3,500 companies, covering various sectors such as cosmetics, personal care, beauty equipment and health products.

Dubai Derma, the leading Dermatology & Laser Event in the Middle East, Africa Market, and Beyond.

Celebrations of Hyaluronic Acid are in order in 2024.

Let us explain !

As we step into the Year of the Dragon, we extend our warmest wishes to all our colleagues, clients, partners, and friends celebrating this joyous occasion.

IMCAS, the world’s leading congress dedicated to dermatology, plastic surgery and aesthetics.

We are excited to announce that we will be participating in the IMCAS 2024 Congress !

Join us for an immersive scientific program with innovation at its core, and network with the world’s leading figures and experts in dermatology and aesthetics.

We can’t wait to see you there !